These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 22527345)
41. The effect of the CYP 2C19*2 polymorphism on stroke care. Nyírő G; Inczédy-Farkas G; Reményi V; Gál A; Pál Z; Molnár MJ Acta Physiol Hung; 2012 Mar; 99(1):33-9. PubMed ID: 22425806 [TBL] [Abstract][Full Text] [Related]
42. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population. Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998 [TBL] [Abstract][Full Text] [Related]
43. Determination of carisoprodol and meprobamate in oral fluid. Coulter C; Garnier M; Tuyay J; Orbita J; Moore C J Anal Toxicol; 2012 Apr; 36(3):217-20. PubMed ID: 22417839 [TBL] [Abstract][Full Text] [Related]
44. A rapid quantitative method of carisoprodol and meprobamate by liquid chromatography-tandem mass spectrometry. Essler S; Bruns K; Frontz M; McCutcheon JR J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 908():155-60. PubMed ID: 23040985 [TBL] [Abstract][Full Text] [Related]
46. High-dose carisoprodol during pregnancy and lactation. Briggs GG; Ambrose PJ; Nageotte MP; Padilla G Ann Pharmacother; 2008 Jun; 42(6):898-901. PubMed ID: 18460586 [TBL] [Abstract][Full Text] [Related]
47. Association of poor metabolizers of cytochrome P450 2C19 with head and neck cancer and poor treatment response. Yadav SS; Ruwali M; Shah PP; Mathur N; Singh RL; Pant MC; Parmar D Mutat Res; 2008 Sep; 644(1-2):31-7. PubMed ID: 18644391 [TBL] [Abstract][Full Text] [Related]
48. Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients. Hirt D; Mentré F; Tran A; Rey E; Auleley S; Salmon D; Duval X; Tréluyer JM; Br J Clin Pharmacol; 2008 Apr; 65(4):548-57. PubMed ID: 17922881 [TBL] [Abstract][Full Text] [Related]
49. Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia. Griese EU; Ilett KF; Kitteringham NR; Eichelbaum M; Powell H; Spargo RM; LeSouef PN; Musk AW; Minchin RF Pharmacogenetics; 2001 Feb; 11(1):69-76. PubMed ID: 11207032 [TBL] [Abstract][Full Text] [Related]
50. Distribution of CYP2C19*2 and CYP2C19*3 polymorphisms in Venezuelan populations with different admixture. Castro de Guerra D; Flores S; Izaguirre MH Ann Hum Biol; 2013 Mar; 40(2):197-200. PubMed ID: 23249123 [TBL] [Abstract][Full Text] [Related]
51. Drug-related information generates placebo and nocebo responses that modify the drug response. Flaten MA; Simonsen T; Olsen H Psychosom Med; 1999; 61(2):250-5. PubMed ID: 10204979 [TBL] [Abstract][Full Text] [Related]
55. Validation of a new homogeneous immunoassay for the detection of carisoprodol in urine. Wang G; Huynh K; Barhate R; Rodrigues W; Moore C; Coulter C; Vincent M; Soares J J Anal Toxicol; 2011 Mar; 35(2):108-12. PubMed ID: 21396230 [TBL] [Abstract][Full Text] [Related]
56. Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir. Mikus G; Schöwel V; Drzewinska M; Rengelshausen J; Ding R; Riedel KD; Burhenne J; Weiss J; Thomsen T; Haefeli WE Clin Pharmacol Ther; 2006 Aug; 80(2):126-35. PubMed ID: 16890574 [TBL] [Abstract][Full Text] [Related]
57. NTP toxicity studies of carisoprodol (CAS No. 78-44-4) administered by Gavage to F344/N rats and B6C3F1 mice. Chan PC Toxic Rep Ser; 2000 Aug; (56):1-G14. PubMed ID: 11986679 [TBL] [Abstract][Full Text] [Related]
58. Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico. Salazar-Flores J; Torres-Reyes LA; Martínez-Cortés G; Rubi-Castellanos R; Sosa-Macías M; Muñoz-Valle JF; González-González C; Ramírez A; Román R; Méndez JL; Barrera A; Torres A; Medina R; Rangel-Villalobos H Genet Test Mol Biomarkers; 2012 Sep; 16(9):1098-104. PubMed ID: 22913530 [TBL] [Abstract][Full Text] [Related]
59. [A case of acute carisoprodol poisoning. Symptoms and metabolism]. Brandslund I Ugeskr Laeger; 1976 Jan; 138(5):281-3. PubMed ID: 1251491 [No Abstract] [Full Text] [Related]
60. Pharmacogenetic associations of CYP2C19 genotype with in vivo metabolisms and pharmacological effects of thalidomide. Ando Y; Price DK; Dahut WL; Cox MC; Reed E; Figg WD Cancer Biol Ther; 2002; 1(6):669-73. PubMed ID: 12642692 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]